Web-based treatment for substance use disorders: differential effects by primary substance
Gerald Cochran, Maxine Stitzer, Aimee N C Campbell, Mei-Chen Hu, Ryan Vandrey, Edward V Nunes, Gerald Cochran, Maxine Stitzer, Aimee N C Campbell, Mei-Chen Hu, Ryan Vandrey, Edward V Nunes
Abstract
Introduction: This secondary analysis of data from a large, multi-site effectiveness trial (NCT01104805) sought to determine whether effects of a web-based behavioral treatment (Therapeutic Education System [TES]) differed by participants' self-identified primary drug of abuse.
Methods: The all-comers sample of individuals entering outpatient psychosocial counseling treatment for substance abuse (N=497) cited cannabis (22.9%; n=114), stimulants (34.4%, n=171), opioids (21.7%, n=108), or alcohol (20.9%, n=104) as their primary substance of abuse. Participants were randomly assigned to receive treatment-as-usual (TAU) with or without TES substituted for approximately 2h of usual counseling. Multivariate analyses of abstinence outcomes examined interactions of treatment effects with primary substance.
Results: Adjusted odds ratios (AORs) demonstrated that primary stimulant users receiving TES were more likely to be abstinent in the final four weeks of treatment compared to stimulant users receiving TAU (AOR=3.59, 95% CI=1.25-10.27). Adjusted odds ratios for alcohol (AOR=3.15, 95% CI=0.85-11.65) and cannabis (AOR=2.64, 95% CI=0.73-9.52) also were of similar magnitude to stimulants but did not reach significance. Abstinence among primary opioid users was not improved by the TES intervention (AOR=0.35, 95% CI=0.09-1.47).
Conclusions: This study supports the TES web-delivered treatment as a viable intervention for the majority of substance users entering outpatient counseling treatment, with demonstrated effectiveness among stimulant users and promising effects in alcohol and cannabis users but little or no effect in primary opioid users. Web-delivered treatments hold promise for expanding the availability of effective behavioral interventions for the majority of substance use disorders.
Keywords: Multi-site clinical trial; Primary substance of abuse; Web-based drug treatment.
Conflict of interest statement
Conflicts of Interest: None
Copyright © 2015 Elsevier Ltd. All rights reserved.
References
- Amato L, Davoli M, Ferri M, Gowing L, Perucci CA. Effectiveness of interventions on opiate withdrawal treatment: an overview of systematic reviews. Drug and Alcohol Dependence. 2004;73:219–226.
- Bickel WK, Marsch LA, Buchhalter AR, Badger GJ. Computerized behavior therapy for opioid-dependent outpatients: A randomized controlled trial. Experimental and Clinical Psychopharmacology. 2008;16:132–143.
- Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, Winhusen T, Ghitza UE. Internet-Delivered Treatment for Substance Abuse: A Multisite Randomized Controlled Trial. American Journal of Pyschiatry. 2014;171(6):683–690.
- Campbell ANC, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, Perez L, McClure E, Goldman B, Crowell AR. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network. Contemporary Clinical Trials. 2012;33:386–395.
- Kypri K. Methodological Issues in Alcohol Screening and Brief Intervention Research. Substance Abuse. 2007;28:31–42.
- Meyers RJ, Roozen HG, Smith JE. The community reinforcement approach: an update of the evidence. Alcohol Research and Health. 2011;33(4):380–388.
- SAS. SAS 9.3. In (Vol. 9.3) Cary, NC: 2011.
- Sobell L, Sobell M. In: Timeline follow-back: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biological Methods. A J, L R, editors. Totowa, NJ: Humana Press; 1992.
- VandenBrink W, Haasen C. Evidenced-based treatment of opioid-dependent patients. Canadian Journal of Psychiatry. 2006;51:635–646.
- WHO. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva, Switzerland: World Health Organization; 2009.
Source: PubMed